CYTOVENE

LOE Approaching

ganciclovir sodium

NDAINJECTIONINJECTABLEPriority Review
Approved
Jun 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

[see Microbiology ()] .

Indications (4)

cytomegalovirus (CMV) retinitis in immunocompromised adult patientsCMV retinitis in immunocompromised adult patientsincluding patients with acquired immunodeficiency syndrome (AIDS)CMV disease in adult transplant recipients at risk for CMV disease

Clinical Trials (1)

NCT00002034N/ACompleted

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

100 enrolled
Cytomegalovirus RetinitisHIV Infections
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers